EurekaMag.com logo
+ Site Statistics
References:
53,214,146
Abstracts:
29,074,682
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Hepatitis C virus transmission by a blood donation negative in nucleic acid amplification tests for viral RNA






Lancet 355(9197): 41-42

Hepatitis C virus transmission by a blood donation negative in nucleic acid amplification tests for viral RNA

Hepatitis C virus (HCV) was transmitted by transfusion of a platelet concentrate made from an anti-HCV and HCV-PCR-negative blood donation. Even a negative nucleic acid amplification test cannot completely prevent transmission of HCV.

Accession: 010743991

PMID: 10615893

DOI: 10.1016/S0140-6736(99)04719-4

Download PDF Full Text: Hepatitis C virus transmission by a blood donation negative in nucleic acid amplification tests for viral RNA



Related references

First report of human immunodeficiency virus transmission via a blood donation that tested negative by 20-minipool nucleic acid amplification in Japan. Transfusion 54(9): 2361-2362, 2015

Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa. Transfusion 49(6): 1115-1125, 2009

Nationwide nucleic acid amplification testing of hepatitis B virus, hepatitis C virus and human immunodeficiency virus type 1 for blood transfusion and follow-up study of nucleic acid amplification positive donors. Japanese Journal of Infectious Diseases 53(3): 116-123, 2000

Nucleic acid amplification technology for hepatitis B virus, and its role in blood donation screening in blood banks. Saudi Medical Journal 30(11): 1416-1421, 2010

Blood donation screening for hepatitis B virus markers in the era of nucleic acid testing: are all tests of value?. Transfusion 52(2): 440-446, 2012

Application of bovine viral diarrhoea virus as an internal control in nucleic acid amplification tests for hepatitis C virus RNA in plasma-derived products. Journal of Microbiology 44(1): 72-76, 2006

Human immunodeficiency virus, hepatitis C and hepatitis B infections among blood donors in Germany 2000-2002: risk of virus transmission and the impact of nucleic acid amplification testing. Euro Surveillance 10(2): 8-11, 2005

High throughput screening of 16 million serologically negative blood donors for hepatitis B virus, hepatitis C virus and human immunodeficiency virus type-1 by nucleic acid amplification testing with specific and sensitive multiplex reagent in Japan. Journal of Virological Methods 112(1/2): 145-151, 2003

Evaluation of an individual-donation nucleic acid amplification testing algorithm for detecting hepatitis B virus infection in Chinese blood donors. Transfusion 55(9): 2272-2281, 2015

A mathematical approach to estimate the efficacy of individual-donation and minipool nucleic acid amplification test options in preventing transmission risk by window period and occult hepatitis B virus infections. Transfusion 54(10): 2496-2504, 2015